New advances in allergy immunotherapy

Area of Science:

• Immunology
• Allergy Research
• Therapeutic Development

Background:

• Specific immunotherapy (SI) aims to treat immunoglobulin E-mediated hypersensitivity.
• Traditional SI faces challenges in allergen standardization and potential for severe reactions.

Purpose of the Study:

• To review novel methods for administering SI for airborne and food allergens.
• Focus on allergen modifications and new delivery routes to allergen-presenting cells.

Main Methods:

• Literature review of recent advancements in SI.
• Analysis of modified allergens (recombinant proteins, enhanced allergenicity).
• Exploration of new delivery strategies (nanoparticles, adjuvants, novel routes).

Main Results:

• Modified allergens improve supply, standardization, and safety profiles.
• Nanoparticle encapsulation and immunostimulatory adjuvants are gaining traction.
• New delivery routes combined with allergen modifications aim to shorten therapy duration and improve adherence.
• Demonstrated safety and long-term efficacy of various novel SI methods.

Conclusions:

• Technological advances are accelerating SI development for allergic diseases.
• SI is recognized as a well-tolerated, efficacious, and cost-effective therapy.
• SI significantly improves long-term quality of life for individuals with allergies.